{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T14:35:24Z","timestamp":1785854124915,"version":"3.56.0"},"reference-count":11,"publisher":"SAGE Publications","issue":"10","license":[{"start":{"date-parts":[[2020,7,21]],"date-time":"2020-07-21T00:00:00Z","timestamp":1595289600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Int J STD AIDS"],"published-print":{"date-parts":[[2020,9]]},"abstract":"<jats:p>We report here the case of a 32-year-old male with recent diagnosis of HIV that, 45\u2009days after starting a single tablet regimen co-formulated with bictegravir, emtricitabine and tenofovir alafenamide (BIC\/FTC\/TAF), experienced severe epigastric pain radiating to the back, nausea, episodes of non-bloody non-bilious vomiting and anorexia. Laboratory examination showed a rise in lipase with no alterations in serum transaminases. Abdominal ultrasound revealed a non-homogeneous structure of the pancreatic parenchyma. A diagnosis of mild drug-related acute pancreatitis was made and BIC\/FTC\/TAF was immediately stopped. The association between the episode of acute pancreatitis and BIC\/FTC\/TAF was scored as probable according to the Naranjo causality scale.<\/jats:p>","DOI":"10.1177\/0956462420934981","type":"journal-article","created":{"date-parts":[[2020,7,22]],"date-time":"2020-07-22T01:26:18Z","timestamp":1595381178000},"page":"1008-1010","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":7,"title":["Bictegravir\/emtricitabine\/tenofovir alafenamide-induced acute pancreatitis: a case report"],"prefix":"10.1177","volume":"31","author":[{"given":"Agostino","family":"Riva","sequence":"first","affiliation":[{"name":"Department of Infectious Diseases, ASST Fatebenefratelli Sacco University Hospital, Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1512-6530","authenticated-orcid":false,"given":"Dario","family":"Cattaneo","sequence":"additional","affiliation":[{"name":"Gestione Ambulatoriale Politerapie (GAP) Outpatient Clinic, ASST Fatebenefratelli Sacco University Hospital, Milan, Italy"},{"name":"Unit of Clinical Pharmacology, ASST Fatebenefratelli Sacco University Hospital, Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlo","family":"Filice","sequence":"additional","affiliation":[{"name":"Infectious Diseases Department, San Matteo Hospital Foundation, University of Pavia, Pavia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4922-6495","authenticated-orcid":false,"given":"Cristina","family":"Gervasoni","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, ASST Fatebenefratelli Sacco University Hospital, Milan, Italy"},{"name":"Gestione Ambulatoriale Politerapie (GAP) Outpatient Clinic, ASST Fatebenefratelli Sacco University Hospital, Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2020,7,21]]},"reference":[{"key":"bibr1-0956462420934981","doi-asserted-by":"publisher","DOI":"10.1111\/hiv.12833"},{"key":"bibr2-0956462420934981","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(17)32299-7"},{"key":"bibr3-0956462420934981","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(17)32340-1"},{"key":"bibr4-0956462420934981","doi-asserted-by":"crossref","first-page":"e347","DOI":"10.1016\/S2352-3018(18)30091-2","volume":"5","author":"Daar ES","year":"2018","journal-title":"Lancet HIV"},{"key":"bibr5-0956462420934981","doi-asserted-by":"crossref","first-page":"e357","DOI":"10.1016\/S2352-3018(18)30092-4","volume":"5","author":"Molina JM","year":"2018","journal-title":"Lancet HIV"},{"key":"bibr6-0956462420934981","doi-asserted-by":"publisher","DOI":"10.1097\/QAI.0000000000002137"},{"key":"bibr7-0956462420934981","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.1981.154"},{"key":"bibr8-0956462420934981","first-page":"45","volume":"15","author":"Jones MR","year":"2015","journal-title":"Ochsner J"},{"key":"bibr9-0956462420934981","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajg.2019.11.005"},{"key":"bibr10-0956462420934981","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0000000000000542"},{"key":"bibr11-0956462420934981","unstructured":"U.S. Food and Drug Administration. FDA Adverse Event Reporting System (FAERS), www.fda.gov\/drugs\/fda-adverse-event-reporting-system-faers (accessed 5 May 2020)."}],"container-title":["International Journal of STD &amp; AIDS"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/0956462420934981","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/0956462420934981","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/0956462420934981","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T22:40:52Z","timestamp":1777675252000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/0956462420934981"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,21]]},"references-count":11,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2020,9]]}},"alternative-id":["10.1177\/0956462420934981"],"URL":"https:\/\/doi.org\/10.1177\/0956462420934981","relation":{},"ISSN":["0956-4624","1758-1052"],"issn-type":[{"value":"0956-4624","type":"print"},{"value":"1758-1052","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,7,21]]}}}